GWM
AKTS icon

GK Wealth Management’s Aktis Oncology AKTS Stock Holding History

GK Wealth Management’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.3K Buy
+1,350
New +$32.9K 0.01% 586

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GK Wealth Management's AKTS Position: Q3 2026 in Review

GK Wealth Management opened a new position in Aktis Oncology (AKTS) in Q3 2026: 1,350 shares worth $26.3K. The stake represents 0.01% of the portfolio and ranks #586 among its holdings.

6 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • GK Wealth Management held 1,350 shares of Aktis Oncology worth $26.3K as of Q3 2026.
  • Aktis Oncology was a new GK Wealth Management position in Q3 2026.
  • Aktis Oncology made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #586 holding.
  • 6 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.